Financials data is unavailable for this security.
View more
Year on year Mesa Laboratories Inc had net income fall from a gain of 930.00k to a loss of 254.25m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 40.10% to 41.72%.
| Gross margin | 62.27% |
|---|---|
| Net profit margin | -111.89% |
| Operating margin | -117.40% |
| Return on assets | -46.23% |
|---|---|
| Return on equity | -92.97% |
| Return on investment | -50.62% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Mesa Laboratories Inc fell by 4.70m. However, the company earned 44.13m from its operations for a Cash Flow Margin of 20.41%. In addition the company generated 32.84m cash from financing while 81.31m was spent on investing.
| Cash flow per share | -41.00 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 27.87 |
|---|---|
| Tangible book value per share | -25.60 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.94 |
|---|---|
| Quick ratio | 1.37 |
| Total debt/total equity | 1.41 |
|---|---|
| Total debt/total capital | 0.5848 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 0.32% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -13,797.16 |
More ▼
